Review of treatment for discoid lupus erythematosus.

Anna Cristina Garza-Mayers, Michael McClurkin, Gideon P Smith

Journal: Dermatologic therapy 2017;29(4):274-83

PMID: 27073142

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Discoid lupus erythematosus (DLE) is a chronic cutaneous disease characterized by inflammatory plaques that, in the absence of prompt diagnosis and treatment, may lead to disfiguring scarring and skin atrophy. However, there is limited evidence for which treatments are most effective. Currently, no medications have been approved specifically for the treatment of DLE. Many of the drugs described in the literature were developed for use in other immune disorders. This review will summarize current therapeutic options for DLE and their supporting evidence with discussion of prevention, topical measures, physical modalities, and systemic therapies, including newer potential therapies.

Address: Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts.

DOI: 10.1111/dth.12358

Link outs

Free resources

Medical:

https://medlineplus.gov/lupus.html

Other Literature Sources:

https://scite.ai/reports/27073142

Subscription / membership required

Full Text Sources:

MeSH Terms: Adrenal Cortex Hormones, Calcineurin Inhibitors, Dapsone, Humans, Hydroxychloroquine, Laser Therapy, Lupus Erythematosus, Discoid, Methotrexate, Phototherapy, Retinoids, Smoking Cessation, Thalidomide